Literature DB >> 19141691

Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes.

Syed Bokhari1, Peter Emerson, Zarmen Israelian, Anchal Gupta, Christian Meyer.   

Abstract

We examined the intracellular metabolic fate of plasma glucose during a hyperglycemic clamp in impaired glucose-tolerant (IGT; n = 21) and normal glucose-tolerant subjects (n = 10) using a combination of [3-(3)H]glucose infusion with measurement of [(3)H]water formation and indirect calorimetry. IGT was associated with approximately 35% reduced first-phase insulin responses, normal second-phase insulin response, and 25-30% reduced insulin sensitivity, resulting in approximately 35% reduced plasma glucose disposal. This was coupled with approximately 55% reduced storage of plasma glucose (P < 0.01) and approximately 15-20% reduced glycolysis of plasma glucose (P < 0.03), accounting for approximately 75 and 25% of the reduction in glucose disposal, respectively. Decreased glucose oxidation accounted for virtually all the decrease in glycolysis. Therefore, nonoxidative glycolysis of plasma glucose in IGT was similar to that in NGT (P > 0.9) and accounted for an increased proportion of systemic glucose disposal (P < 0.05). We conclude that, in IGT, decreased disposal of plasma glucose involves mainly decreased glycogen synthesis and to a lesser extent decreased glycolysis, which is accounted for by decreased glucose oxidation. An increased proportion of plasma glucose hence undergoes nonoxidative glycolysis, representing a novel early abnormality in the pathogenesis of T2DM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141691     DOI: 10.1152/ajpendo.90505.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  3 in total

1.  Role of Altered Venous Blood Lactate and HbA1c in Women with Gestational Diabetes Mellitus.

Authors:  C S Nagalakshmi; N U Santhosh; N Krishnamurthy; Chethana Chethan; M K Shilpashree
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 2.  Lactate, a Neglected Factor for Diabetes and Cancer Interaction.

Authors:  Yong Wu; Yunzhou Dong; Mohammad Atefi; Yanjun Liu; Yahya Elshimali; Jaydutt V Vadgama
Journal:  Mediators Inflamm       Date:  2016-12-18       Impact factor: 4.711

3.  LACTATE CAN BE A MARKER OF METABOLIC SYNDROME IN SEVERE OBESITY?

Authors:  Roberto DE-Cleva; Lilian Cardia; Alexandre Vieira-Gadducci; Julia Maria Greve; Marco Aurelio Santo
Journal:  Arq Bras Cir Dig       Date:  2021-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.